Clinical Significance of Low Transferrin Levels

Interpretation Framework

Low transferrin with high ferritin (>300 ng/mL) and low transferrin saturation (<20%) indicates anemia of chronic disease/inflammation, not iron deficiency, in patients with inflammatory conditions, according to the American Journal of Hematology 1, 2
Transferrin acts as a negative acute-phase reactant, decreasing during inflammation, infection, or malignancy, as reported in the Journal of Crohn's and Colitis 3
In congestive heart failure patients, low transferrin reflects inflammatory cytokine production (TNF-α, IL-6) that suppresses erythropoiesis and increases hepcidin, as noted in the American Journal of Hematology 1, 2

The American Journal of Hematology recommends evaluating ferritin levels alongside transferrin to determine the significance of low transferrin, as low ferritin (<15-50 ng/mL) with low transferrin suggests true iron deficiency, while high ferritin (>100-300 ng/mL) suggests inflammation 3, 4
The MMWR Recommendations and Reports suggest calculating transferrin saturation (TSAT) as (serum iron/TIBC) × 100, where TSAT <16-20% indicates iron-restricted erythropoiesis, and TSAT >50% may indicate iron overload 3, 4, 5, 6, 7
The Journal of Crohn's and Colitis recommends checking inflammatory markers, such as CRP and ESR, to identify inflammatory states that confound interpretation 3

The American Journal of Hematology warns against assuming low transferrin equals iron deficiency, as in inflammatory conditions, ferritin rises as an acute-phase reactant while transferrin falls, masking true iron status 1, 3
The Journal of Hepatology notes that ignoring clinical context, such as in haemochromatosis patients on phlebotomy, can lead to misinterpretation of transferrin saturation fluctuations 6, 7, 8
The American Journal of Hematology advises against evaluating transferrin and iron parameters within 4 weeks of IV iron administration due to assay interference 4

Normal transferrin ranges typically fall between 200-360 mg/dL in most laboratories, though a level of 174 mg/dL may still be considered low-normal or mildly decreased depending on the reference range used, according to the American Journal of Kidney Diseases guidelines 9, 10
Transferrin is a negative acute-phase reactant, meaning it decreases during inflammation, infection, or malignancy, independent of iron status, as noted by the American Journal of Kidney Diseases 10

In patients with chronic inflammatory conditions, such as inflammatory bowel disease, heart failure, or chronic kidney disease, transferrin levels decrease as part of the acute-phase response, making it a poor marker of nutritional status in these populations, as stated by the American Journal of Kidney Diseases 10
In chronic kidney disease patients on dialysis, transferrin has limited utility due to confounding from chronic blood loss, erythropoietin therapy, and IV iron administration, and serum albumin is preferred for nutritional assessment, according to the American Journal of Kidney Diseases guidelines 9, 10
For nutritional assessment in chronic disease, the American Journal of Kidney Diseases recommends using serum albumin and prealbumin rather than transferrin, as they provide more specific information about protein-energy malnutrition 9, 10